The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Study Looks at Factors Recorded on a Standard Clinical History and Change in Opioid Use After Neurostimulation for Chronic Pain

June 14, 2019 - In a chart analysis, a team of U.S. co-authors looked for factors that were statistically associated with cessation of chronic opioid use following successful spinal cord stimulation, such as the dosage used preoperatively. (Pain Practice)

PROMISE Trial Results Published

June 2019 - A prospective, open-label, parallel-group trial in Europe and the Americas, PROMISE, compared optimal medical management (OMM) alone vs. OMM plus multicolumn spinal cord stimulation in patients with predominant low back pain from failed back surgery syndrome. (Pain)

Canadian Provincial Advisory Body Seeks Public Input on Proposed Expansion of Frequencies in its Recommendation for Public Funding of Spinal Cord Stimulation for Chronic Pain

June 17, 2019 - The advisory body Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory committee, seeks public input by July 8, 2019 on a proposed update of stimulation frequencies in its recommendation concerning public funding for spinal cord stimulation in adults with chronic non-cancer pain that is refractory to medical management. (Health Quality Ontario)

FDA Approves a Cochlear Implant Designed for MRI Compatibility

June 17, 2019 - The U.S. FDA has approved a new cochlear implant designed for compatibility with 1.5. and 3.0 Tesla MRI scans. The FDA also approved an integrated connectivity feature that allows streaming audio from compatible Android phones. (MD Magazine)

Physicians Publish Protocol for Adaptive Deep Brain Stimulation in Parkinson's Disease Patients

June 14, 2019 - Physicians in Europe have published a protocol for testing adaptive deep brain stimulation in Parkinson's disease patients who will be undergoing a battery replacement. (DocWire News)

Case Series Reports on Neurostimulation for Restless Legs Syndrome

May 2019 - A team of co-authors published a case series of mechanistic hypothesis about spinal cord stimulation for restless legs syndrome. (Stereotactic and Functional Neurosurgery)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM